RD Lewis Holdings, Inc.

Position in LLY — ELI LILLY & Co

CIK 2046179 MAITLAND, FL

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,845,372

+$1,158,724 QoQ

Shares Held

3,206

+9.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.92%

of 13F equity value

Holder Rank

#1,924

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RD Lewis Holdings, Inc. holds $7,678,402 across 6 Drug Manufacturers - General names. LLY ranks #1 (50.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,206	$3,845,372
2	JNJ	Johnson & Johnson	5,868	$1,490,295
3	NVS	Novartis AG	8,071	$1,264,887
4	PFE	Pfizer Inc	18,387	$442,758
5	MRK	Merck & Co., Inc.	3,266	$419,681
6	GILD	Gilead Sciences, Inc.	1,705	$215,409

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,845,372	3,206	+9.8%	Shares	Sole	2026-08-12
2026-03-31	$2,686,648	2,921	-1.0%	Shares	Sole	2026-04-14
2025-12-31	$3,171,380	2,951	+2.8%	Shares	Sole	2026-02-06
2025-09-30	$2,191,336	2,872	+7.9%	Shares	Sole	2025-11-13
2025-06-30	$2,074,329	2,661	-0.2%	Shares	Sole	2025-08-12
2025-03-31	$2,201,876	2,666	+4.8%	Shares	Sole	2025-05-05
2024-12-31	$1,964,740	2,545	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.